Allogene Therapeutics
Total Awards:
1
Award Value:
$15,000,000
Institution type:
For profit
Short Name:
Allogene Therapeutics
Awards to the Institution
| Program Type | Investigator | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Dr. John Le Gall | A PHASE 1B STUDY EVALUATING THE SAFETY AND EFFICACY OF AN ALLOGENEIC CELL THERAPY IN SUBJECTS WITH CLEAR CELL RENAL CELL CARCINOMA (ccRCC) | $15,000,000 |
| Total: $15,000,000.00 |